Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Rothia mucilaginosa Pneumonia Diagnosed by Quantitative Cultures and Intracellular Organisms of Bronchoalveolar Lavage in a Lymphoma Patient

  • Cho, Eun-Jung (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Sung, Heungsup (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Park, Sook-Ja (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Kim, Mi-Na (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Lee, Sang-Oh (Department of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center)
  • Published : 2013.03.02
⟨ Previous Next ⟩

Abstract

Rothia mucilaginosa is a gram-positive coccus of the family Micrococcaceae. R. mucilaginosa is considered a part of the normal flora of the human oropharynx and upper respiratory tract and lower respiratory tract infections attributable to R. mucilaginosa are not frequent. We present a case of pneumonia, in which the R. mucilaginosa infection was diagnosed by quantitative cultures of a bronchoalveolar lavage (BAL) specimen. A 46-yr-old woman with B lymphoblastic lymphoma was admitted to the hospital for scheduled chemotherapy. Her chest computed tomography (CT) scan revealed bilateral multifocal nodular and patchy consolidation in both lungs. Investigation of the BAL specimen revealed that 7% of leukocytes had intracellular gram-positive cocci. The quantitative cultures of the BAL specimen grew mucoid, non-hemolytic, and grayish convex colonies on blood agar at a count of approximately 200,000 colony-forming units/mL. The colonies were identified as R. mucilaginosa. The patient was empirically treated with levofloxacin for 7 days, after which findings on the chest radiograph and CT scan improved. She was discharged with improvement on hospital day 46. To our knowledge, this is the first report of R. mucilaginosa pneumonia diagnosed in Korea. Quantitative culture of BAL specimen and examination of intracellular organisms are crucial for assessing the clinical significance of R. mucilaginosa recovered from the lower respiratory tract.

Keywords

References

  1. Becker K and von Eiff C. Staphylococcus, Micrococcus and other catalase-positive cocci. In: Becker K, Christof von EIFF, Bernard KA, Carroll KC, and Versalovic J, ed. Manual of clinical microbiology. 10th ed. Washington DC: American Society for Microbiology, 2011:308-30.
  2. Rubin SJ, Lyons RW, Murcia AJ. Endocarditis associated with cardiac catheterization due to a Gram-positive coccus designated Micrococcus mucilaginosus incertae sedis. J Clin Microbiol 1978;7:546-9.
  3. Faiad G, Singh M, Narasimhan A, Mendez M, Shama S, Nassar N. Rothia mucilaginosa life threatening infections in non-neutropenic hosts. Open Journal of Internal Medicine 2011;1:68-71. https://doi.org/10.4236/ojim.2011.13014
  4. Ascher DP, Zbick C, White C, Fischer GW. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991;13:1048-52. https://doi.org/10.1093/clinids/13.6.1048
  5. Trevino M, Garcia-Zabarte A, Quintas A, Varela E, Lopez-Paz JM, Jato A, et al. Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia. Eur J Clin Microbiol Infect Dis 1998;17:505-7. https://doi.org/10.1007/BF01691134
  6. Korsholm TL, Haahr V, Prag J. Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus. Scand J Infect Dis 2007;39:913-7. https://doi.org/10.1080/00365540701387064
  7. Lambotte O, Debord T, Soler C, Roue R. Pneumonia due to Stomatococcus mucilaginosus in an AIDS patient: case report and literature review. Clin Microbiol Infect 1999;5:112-4. https://doi.org/10.1111/j.1469-0691.1999.tb00116.x
  8. Sanchez-Carrillo C, Cercenado E, Cibrian F, Bouza E. Stomatococcus mucilaginosus pneumonia in a liver-transplant patient. Clin Microbiol Newsl 1995;16:150-1.
  9. Cunniffe JG, Mallia C, Alcock PA. Stomatococcus mucilaginosus lower respiratory tract infection in a patient with AIDS. J Infect 1994;29:327-30. https://doi.org/10.1016/S0163-4453(94)91312-9
  10. Clinical Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline 2nd ed, M45-A2. Wayne, PA: Clinical Laboratory Standards Institute, 2010:18-9.
  11. Cantral DE, Tape TG, Reed EC, Spurzem JR, Rennard SI, Thompson AB. Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med 1993;95:601-7. https://doi.org/10.1016/0002-9343(93)90356-T
  12. Allaouchiche B, Jaumain H, Dumontet C, Motin J. Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid? Chest 1996;110:1558-65. https://doi.org/10.1378/chest.110.6.1558
  13. Torres A, El-Ebiary M, Fabregas N, Gonzailez J, de la Bellacasa JP, Hernández C, et al. Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia. Thorax 1996;51:378-84. https://doi.org/10.1136/thx.51.4.378
  14. Sole-Violan J, Rodriguez de Castro F, Rey A, Martin-Gonzalez JC, Cabrera-Navarro P. Usefulness of microscopic examination of intracellular organisms in lavage fluid in ventilator-associated pneumonia. Chest 1994;106:889-94. https://doi.org/10.1378/chest.106.3.889
  15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. https://doi.org/10.1016/j.ajic.2008.03.002
  16. Garcia LS and Isenberg HD, ed. Clinical microbiology procedures handbook. 3rd ed. Washington DC: ASM Press, 2010:1:3.11.2.173.11.2.20-7.
  17. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995;39:268-70. https://doi.org/10.1128/AAC.39.1.268
  18. von Eiff C and Peters G. In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients. Eur J Clin Microbiol Infect Dis 1998;17:890-2. https://doi.org/10.1007/s100960050218
  19. Skogen PG, Kolmannskog S, Bergh K. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child. Clin Microbiol Infect 2001;7:39-42. https://doi.org/10.1046/j.1469-0691.2001.00182.x
  20. McWhinney PH, Kibbler CC, Gillespie SH, Patel S, Morrison D, Hoffbrand AV, et al. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992;14:641-6. https://doi.org/10.1093/clinids/14.3.641
  21. Chomarat M, Vital MG, Flandrois JP. Susceptibility to aminoglycosides of 63 strains of Stomatococcus mucilaginosus isolated from sputum. Zentralbl Bakteriol 1991;276:63-7. https://doi.org/10.1016/S0934-8840(11)80219-7
  22. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-Second Informational supplement, M100-S22. Wayne, PA: Clinical Laboratory Standards Institute, 2012:70-9.
  23. Capitano B, Mattoes HM, Shore E, O'Brien A, Braman S, Sutherland C, et al. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 2004;125:965-73. https://doi.org/10.1378/chest.125.3.965
  24. Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 2002;62:13-59. https://doi.org/10.2165/00003495-200262010-00002

Cited by

  1. Rothia aeria Infective Endocarditis: a First Case in Korea and Literature Review vol.34, pp.4, 2014, https://doi.org/10.3343/alm.2014.34.4.317
  2. Rothia mucilaginosa pneumonia: a literature review vol.47, pp.3, 2013, https://doi.org/10.3109/00365548.2014.980843
  3. Cloacal Microbiome Structure in a Long-Distance Migratory Bird Assessed Using Deep 16sRNA Pyrosequencing vol.10, pp.9, 2013, https://doi.org/10.1371/journal.pone.0137401
  4. Utility of 16S rDNA Sequencing for Identification of Rare Pathogenic Bacteria vol.30, pp.6, 2013, https://doi.org/10.1002/jcla.21980
  5. DETECTION OF AEROSOLIZED BACTERIA IN EXPIRED AIR SAMPLES FROM ASIAN ELEPHANTS (ELEPHAS MAXIMUS) vol.48, pp.2, 2013, https://doi.org/10.1638/2016-0119r.1
  6. Evaluation of Oral Cavity DNA Extraction Methods on Bacterial and Fungal Microbiota vol.9, pp.None, 2013, https://doi.org/10.1038/s41598-018-38049-6
  7. Rothia mucilaginosa bacteremia, meningitis leading to diffuse cerebritis in an adolescent patient undergoing acute myeloid leukemia chemotherapy causing significant morbidity vol.9, pp.None, 2021, https://doi.org/10.1177/2050313x211063745